{"text_format":"2","workbook":"xlsx","n_sheets":3,"sheets":["Form E Technical Bid Form","Form F Price Schedule Sheet","Form G  Discount & DL"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Form E Technical Bid Form","index":0,"n_rows":21,"n_cols":23,"rows_kept":21,"cut":false,"hidden":false,"merged":[[1,0,1,9],[0,0,0,7],[0,8,0,9]]}
["From E Technical Bid Form\n286-2021-HEP-LTA\nEstablishment of UNDP Long Term Agreement (LTAs) for Anti-Hepitits Medicines"]
["Instructions: Bidders shall fill in the grey cells. Please submit this document duly signed as part of your offer in response to the ITB. We request to kindly send this Form both as a signed PDF and in excel format"]
["#","Product Descritpion","Strength","Dosage Form","Type of Packaging","Pack Size","Dosage Form Offered","Type of Packaging Offered","Number of units per primary pack","Number of primary packs per secondary pack","WHO PQ Reference","USA FDA Registration No.","ERP Approval (Validity Date)","Total Approved Shelf Life (in months)","Manufacturing Site Full Address (manufacturing unit, plant, plot, city, region, country, etc…","Production Capacity ( No. of Packs Per Month)","Standard Manufacturing Lead (in weeks)","Maximum FCA Delivery Time (Port/ Airport) in Weeks","FCA Port Destination Name (as applicable)","FCA Airport Destination Name (as applicable)","Artwork, Packaging and Labelling Available in English, French, Portuguese, Spanish, Russian \n(Specify Languages)","Minimum Order Quantity \"MOQ\" (only when and if applicable)","Implementation of GS1 Barcoding Standard \n(YES/NO)"]
[1,"Sofosbuvir"," 400 mg","Tablet","HDPE Bottle",28]
[2,"Daclatasvir (dihydrochloride)","60 mg","Tablet","HDPE Bottle/ Blister Pack",28]
[3,"Ledipasvir + sofosbuvir ","90 mg+ 400 mg","Tablet","HDPE Bottle",28]
[4,"Sofosbuvir + Velpatasvir  ","400mg+100mg","Tablet","HDPE Bottle ",28]
[5,"Daclatasvir + Sofosbuvir ","60mg + 400mg","Tablet","Blister Pack or HDPE Bottle",28]
[6,"Ribavirin","200 mg","Tablet","HDPE Bottle",28]
[7,"Entecavir ","0,5mg ","Tablet","HDPE Bottle",30]
[8,"Entecavir ","1mg","Tablet","HDPE Bottle ",30]
[]
[]
["Name of the company"]
[]
[]
[]
[]
["Signature of Personnel"]
["Name and title"]
["Date (Day/Month/Year)"]

{"sheet":"Form F Price Schedule Sheet","index":1,"n_rows":26,"n_cols":14,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,0,0,8],[0,9,0,10],[16,9,16,10],[2,0,2,10],[3,0,3,10],[4,0,4,10],[5,0,5,10]]}
["Form F Price Schedule\n286-2021-HEP-LTA\nEstablishment of UNDP Long Term Agreement (LTAs) for Anti-Hepitits Medicines"]
[]
["Instruction: Bidders shall fill in the grey cells. We request to kindly send this Form both as a signed PDF and in excel format."]
["* The quantities listed below are provided as a good faith estimates for three years volume and must not be deemed a firm commitment on the part of UNDP regarding any quantity for future purchases. Actual quantities to be ordered will depend on future requests from UNDP Country Offices and estimates may not be reached or may be exceeded.                                                                                                                                                                                                                                                                    "]
["* This is a non-exhaustive indicative list of products  used for evaluation purposes only. UNDP will not be committed to purchase any minimum quantity of these products and shall not be liable for any cost in the event that no purchases are made under any resulting LTA. Actual list of products for RFQs can include a wider or shorter range of products.           "]
["* All prices shall be quoted in USD. In the event, the quote is offered in different currency than preferred currency, UNDP will convert the currency quoted in the Bid into the UNDP preferred currency, in accordance with the prevailing UN operational rate of exchange on the last day of submission of Bid."]
[]
["#","Product description","Strength","Dosage form","Type of packaging","Pack Size","Quantity in no. of Packs/ Three Years Estimate","Quantity in no. of Tabs / Three Years Estimate","Dosage form offered ","Type of packaging offered","Offered Product LTA ceiling price per unit in Year 1  (FCA terms*, USD / pack)","Offered Product LTA ceiling price per unit in Year 2  (FCA terms*, USD / pack)","Total Amount in USD  without cummulative discount ","Comments"]
[1,"Sofosbuvir"," 400 mg","Tablet","HDPE Bottle",28,180000,5040000,{"$nulls":4},{"$f":"G9*K9","v":0}]
[2,"Daclatasvir (dihydrochloride)","60 mg","Tablet","HDPE Bottle/ Blister Pack",28,180000,5040000,{"$nulls":4},{"$f":"G10*K10","v":0}]
[3,"Ledipasvir + sofosbuvir ","90 mg+ 400 mg","Tablet","HDPE Bottle",28,50000,1400000,{"$nulls":4},0]
[4,"Sofosbuvir + Velpatasvir  ","400mg+100mg","Tablet","HDPE Bottle ",28,150000,4200000,{"$nulls":4},0]
[5,"Daclatasvir + Sofosbuvir ","60mg + 400mg","Tablet","Blister Pack or HDPE Bottle",28,30000,840000," ",null,null,null,0]
[6,"Ribavirin","200 mg","Tablet","HDPE Bottle",28,15000,420000,{"$nulls":4},0]
[7,"Entecavir ","0,5mg ","Tablet","HDPE Bottle",30,15000,450000,{"$nulls":4},0]
[8,"Entecavir ","1mg","Tablet","HDPE Bottle ",30,15000,450000,{"$nulls":4},0]
[{"$nulls":9},"TOTAL AMOUNT in USD",null,null,{"$f":"SUM(M9:M16)","v":0}]
[]
["Name of the company"]
[]
[]
[]
[]
["Signature of Personnel"]
["Name and title"]
["Date (Day/Month/Year)"]

{"sheet":"Form G  Discount & DL","index":2,"n_rows":43,"n_cols":2,"rows_kept":43,"cut":false,"hidden":false,"merged":[[11,1,11,6],[17,0,17,8],[18,0,18,3],[0,0,0,7],[7,1,7,6],[8,1,8,6],[9,1,9,6],[10,1,10,6],[2,0,6,8]]}
["Form G Price Schedule\n286-2021-HEP-LTA\nEstablishment of UNDP Long Term Agreement (LTAs) for Anti-Hepitits Medicines"]
["Instruction: Bidders shall fill in the grey cells. We request to kindly send this Form both as a signed PDF and in excel format."]
["Bidders are required to stipulate in this form \"Form G\", Cumulative Volume discount, any percentage discount that will be made available to UNDP based on cumulative contracted value over the duration of the resulting LTAs. The LTA holders are expected to reimburse the accumulated volume discount applicable on annual basis, centrally to UNDP. Applicable cumulative volume percentage discounts will be calculated into final offered costs when conducting the evaluation of the incoming offers in response to the announced RFQs issued by UNDP under the secondary bidding process. The purchase orders will be issued after factoring in the applicable volume discount (e.g. USD 200,000*2% VD=USD 196,000 PO value).  The cumulative volume discount should be credited by the supplier to UNDP’s designated account within 30 days after the issuance of volume discount letter.\nThe quoted Volume discount percentage will not be factored in the evaluation process related to the establishment of LTAs (initial process) under this ITB."]
[]
[]
[]
[]
["Cumulative value of orders channelled through LTA agreement.[1]","Cumulative discount offered (percentage)"]
["Above     U$  1 Mio "]
["Between U$ 1 Mio and U$ 2 Mio"]
["Between U$ 2 Mio and U$ 3 Mio"]
["From U$ 3 Mio and above "]
["[1] Bidders are requested to note that the values and thresholds included in the table are suggested and may be modified by the bidders during submission of their offers."]
[]
[null,"Fixed amount in USD"]
["Price of 1 USB data logger*  "]
[]
["*Data loggers are required to be included in all pharmaceutical products to UNDP Country Offices during international transport and transit to monitor the goods from the moment they leave the manufacturer."]
["The minimum technical requirements for dataloggers are as follows:"]
["§  WHO prequalified data logger device[1] "]
["§  Measures temperature (from -30° to +45°C, with accuracy +/- 0.5°c)."]
["§  Readings to include time and date"]
["§  Single or multiple use"]
["§  Direct USB interface, without need for additional cable"]
["§  Automatically creates PDF report when connected to computer."]
["§  Rapid data download to graph"]
["§  Alarm levels set up before shipping according to manufacturer’s storage requirements"]
["§  LCD featuring up to 1 decimal point readings"]
["§  Alarm indication on LCD screen"]
["§  Sampling rate: at least 1 measure per hour"]
["§  Push button to activate and stop logging."]
["§  Easy to understand user’s guide & instructions"]
[]
[]
["Name of the company"]
[]
[]
[]
[]
[]
["Signature of Personnel"]
["Name and title"]
["Date (Day/Month/Year)"]